Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionnuclear import signal receptor activity

RANBP6 KPNA6 IPO4

2.03e-04201163GO:0061608
GeneOntologyMolecularFunctionpurine ribonucleotide transmembrane transporter activity

SLC25A42 SLC25A25 ABCD1

3.11e-04231163GO:0005346
GeneOntologyMolecularFunctionadenine nucleotide transmembrane transporter activity

SLC25A42 SLC25A25 ABCD1

4.51e-04261163GO:0000295
GeneOntologyMolecularFunctionphosphatidylinositol phospholipase C activity

GDPD5 PLCL1 PLCG1

4.51e-04261163GO:0004435
GeneOntologyMolecularFunctionadenosine 3',5'-bisphosphate transmembrane transporter activity

SLC25A42 ABCD1

4.94e-0461162GO:0071077
GeneOntologyMolecularFunctionnuclear localization sequence binding

RANBP6 KPNA6 IPO4

5.05e-04271163GO:0008139
GeneOntologyMolecularFunctionpurine nucleotide transmembrane transporter activity

SLC25A42 SLC25A25 ABCD1

6.25e-04291163GO:0015216
GeneOntologyMolecularFunctionphospholipase C activity

GDPD5 PLCL1 PLCG1

6.25e-04291163GO:0004629
GeneOntologyMolecularFunctionnucleocytoplasmic carrier activity

RANBP6 KPNA6 IPO4

8.38e-04321163GO:0140142
GeneOntologyMolecularFunctionnucleotide transmembrane transporter activity

SLC25A42 SLC25A25 ABCD1

9.18e-04331163GO:0015215
GeneOntologyBiologicalProcessneuron development

FAT4 RPGRIP1L ZFYVE27 KALRN FAT3 ETV4 APOA4 PLXND1 PARP6 CDKL5 PTK2B GDPD5 AP2A1 GLI2 HPRT1 UGDH PRICKLE2 RAPGEF2 SEPTIN7 SCLT1 PALLD TOP2B

1.68e-05146311522GO:0048666
DomainPH_dom-like

CNKSR1 FGD2 KALRN MYO7B SHC3 PTK2B PHLDB1 PLCL1 PLCG1 ARHGEF2 AGAP1

4.67e-0542611111IPR011993
Domain-

CNKSR1 FGD2 KALRN MYO7B SHC3 PHLDB1 PLCL1 PLCG1 ARHGEF2 AGAP1

1.14e-04391111102.30.29.30
DomainGraves_DC

SLC25A42 SLC25A25

2.08e-0441112IPR002167
DomainPH

CNKSR1 FGD2 KALRN PHLDB1 PLCL1 PLCG1 ARHGEF2 AGAP1

2.56e-042781118SM00233
DomainPH_DOMAIN

CNKSR1 FGD2 KALRN PHLDB1 PLCL1 PLCG1 ARHGEF2 AGAP1

2.62e-042791118PS50003
DomainPH_domain

CNKSR1 FGD2 KALRN PHLDB1 PLCL1 PLCG1 ARHGEF2 AGAP1

2.69e-042801118IPR001849
DomainAnaphylatoxin_comp_syst

C4A C4B

3.46e-0451112IPR018081
DomainAnaphylatoxn_comp_syst_dom

C4A C4B

3.46e-0451112IPR001840
DomainIPT_NFkappaB

REL NFKB2

3.46e-0451112IPR033926
DomainRHD_CS

REL NFKB2

3.46e-0451112IPR030492
Domain-

RANBP6 KPNA6 IPO4 ATAD2 AP2A1 ASPM RIPOR1

3.64e-0422211171.25.10.10
Domain-

GDPD5 PLCL1 PLCG1

4.27e-042511133.20.20.190
DomainPLC-like_Pdiesterase_TIM-brl

GDPD5 PLCL1 PLCG1

4.27e-04251113IPR017946
DomainPH

CNKSR1 FGD2 KALRN PHLDB1 PLCG1 ARHGEF2 AGAP1

4.38e-042291117PF00169
DomainIPT

REL PLXND1 NFKB2

5.39e-04271113SM00429
DomainANATO

C4A C4B

7.21e-0471112SM00104
DomainANAPHYLATOXIN_2

C4A C4B

7.21e-0471112PS01178
DomainANAPHYLATOXIN_1

C4A C4B

7.21e-0471112PS01177
DomainANATO

C4A C4B

7.21e-0471112PF01821
DomainAnaphylatoxin/fibulin

C4A C4B

7.21e-0471112IPR000020
DomainIPT

REL PLXND1 NFKB2

8.94e-04321113IPR002909
DomainARM-type_fold

RANBP6 KPNA6 APOB IPO4 URB1 AP2A1 ASPM RIPOR1

9.47e-043391118IPR016024
DomainMacrogloblnA2_thiol-ester-bond

C4A C4B

9.57e-0481112IPR019565
DomainThiol-ester_cl

C4A C4B

9.57e-0481112PF10569
DomainMacrogloblnA2_CS

C4A C4B

9.57e-0481112IPR019742
DomaincNMP

KCNH4 PRKG2 RAPGEF2

1.07e-03341113SM00100
DomainEF-hand_8

LPCAT1 CAPN3 SLC25A25

1.07e-03341113PF13833
DomaincNMP_binding

KCNH4 PRKG2 RAPGEF2

1.07e-03341113PF00027
DomainARM-like

RANBP6 KPNA6 IPO4 ATAD2 AP2A1 ASPM RIPOR1

1.15e-032701117IPR011989
DomaincNMP-bd_dom

KCNH4 PRKG2 RAPGEF2

1.16e-03351113IPR000595
DomainCNMP_BINDING_3

KCNH4 PRKG2 RAPGEF2

1.16e-03351113PS50042
DomaincNMP-bd-like

KCNH4 PRKG2 RAPGEF2

1.48e-03381113IPR018490
DomainRHD_dimer

REL NFKB2

1.53e-03101112IPR032397
DomainRHD_dimer

REL NFKB2

1.53e-03101112PF16179
DomainREL_1

REL NFKB2

1.53e-03101112PS01204
DomainA2M

C4A C4B

1.53e-03101112PF00207
DomainA2M_N_2

C4A C4B

1.53e-03101112IPR011625
DomainA2M_comp

C4A C4B

1.53e-03101112IPR011626
DomainA2M_recep

C4A C4B

1.53e-03101112PF07677
DomainA2M_comp

C4A C4B

1.53e-03101112PF07678
Domain-

REL NFKB2

1.53e-031011122.60.40.340
DomainA2M_N

C4A C4B

1.53e-03101112PF01835
DomainA2M_N

C4A C4B

1.53e-03101112IPR002890
DomainA-macroglobulin_rcpt-bd

C4A C4B

1.53e-03101112IPR009048
DomainNFkB/Dor

REL NFKB2

1.53e-03101112IPR000451
DomainALPHA_2_MACROGLOBULIN

C4A C4B

1.53e-03101112PS00477
DomainRHD_DNA_bind_dom

REL NFKB2

1.53e-03101112IPR011539
DomainRHD_DNA_bind

REL NFKB2

1.53e-03101112PF00554
DomainA2M_N_2

C4A C4B

1.53e-03101112PF07703
DomainREL_2

REL NFKB2

1.53e-03101112PS50254
DomainMacroglobln_a2

C4A C4B

1.53e-03101112IPR001599
Domain-

KCNH4 PRKG2 RAPGEF2

2.91e-034811132.60.120.10
DomainSH2

SHC3 SHE PLCG1 SH2D7

3.10e-031011114PF00017
DomainRmlC-like_jellyroll

KCNH4 PRKG2 RAPGEF2

3.46e-03511113IPR014710
DomainEF-hand_like

PLCL1 PLCG1

3.49e-03151112PF09279
DomainPI-PLC-Y

PLCL1 PLCG1

3.49e-03151112PF00387
DomainPLCYc

PLCL1 PLCG1

3.49e-03151112SM00149
DomainPLipase_C_Pinositol-sp_Y

PLCL1 PLCG1

3.49e-03151112IPR001711
DomainPIPLC_Y_DOMAIN

PLCL1 PLCG1

3.49e-03151112PS50008
DomainPI-PLC_fam

PLCL1 PLCG1

3.49e-03151112IPR001192
DomainPLC_EF-hand-like

PLCL1 PLCG1

3.49e-03151112IPR015359
DomainSH2

SHC3 SHE PLCG1 SH2D7

4.21e-031101114SM00252
DomainSH2

SHC3 SHE PLCG1 SH2D7

4.35e-031111114PS50001
DomainSH2

SHC3 SHE PLCG1 SH2D7

4.49e-031121114IPR000980
Domain-

SHC3 SHE PLCG1 SH2D7

4.49e-0311211143.30.505.10
DomainC345C

C4A C4B

4.49e-03171112SM00643
DomainVWA

VWF ITGAX CLCA2

4.50e-03561113PF00092
Domain-

LPCAT1 SPTA1 CAPN3 SLC25A25 PLCL1 PLCG1

4.69e-0326111161.10.238.10
DomainPI-PLC-X

PLCL1 PLCG1

5.03e-03181112PF00388
DomainTerpenoid_cyclase/PrenylTrfase

C4A C4B

5.03e-03181112IPR008930
DomainHATPase_c

MORC4 TOP2B

5.03e-03181112SM00387
DomainPLCXc

PLCL1 PLCG1

5.03e-03181112SM00148
DomainNTR

C4A C4B

5.60e-03191112PF01759
DomainNetrin_module_non-TIMP

C4A C4B

5.60e-03191112IPR018933
DomainHATPase_c

MORC4 TOP2B

5.60e-03191112PF02518
DomainPIPLC_X_DOMAIN

PLCL1 PLCG1

5.60e-03191112PS50007
DomainPLipase_C_PInositol-sp_X_dom

PLCL1 PLCG1

5.60e-03191112IPR000909
PathwayREACTOME_MAPK_FAMILY_SIGNALING_CASCADES

FOXO3 CNKSR1 ERBB4 VWF KALRN SPTA1 ETV4 SHC3 PRKG2 RAPGEF2 SEPTIN7

7.18e-063279011M27565
PathwayREACTOME_MAPK_FAMILY_SIGNALING_CASCADES

FOXO3 CNKSR1 ERBB4 VWF KALRN SPTA1 ETV4 SHC3 RAPGEF2 SEPTIN7

3.43e-053189010MM15278
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

FOXO3 EHBP1 REL XPA TBL1XR1 AXIN1 CRY2 SRRT SETDB1 PHLDB1 AP2A1 NFKB2 RIPOR1 RAPGEF2 SEPTIN7 AGAP1

3.76e-0710381161626673895
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

VWF KALRN SPTA1 CDKL5 PTK2B SRRT PHLDB1 AP2A1 SVIL PRICKLE2 C4A C4B PLCL1 ARHGEF2 RAPGEF2 SEPTIN7 CROCC

5.48e-0614311161737142655
Pubmed

Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.

C4A C4B

1.10e-052116222737222
Pubmed

Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.

C4A C4B

1.10e-052116216565498
Pubmed

Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.

C4A C4B

1.10e-052116215998580
Pubmed

High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.

C4A C4B

1.10e-052116219062096
Pubmed

Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.

C4A C4B

1.10e-052116219933335
Pubmed

Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.

C4A C4B

1.10e-05211622459207
Pubmed

Antigen-induced B cell apoptosis is independent of complement C4.

C4A C4B

1.10e-052116217645767
Pubmed

Anti-DNA autoreactivity in C4-deficient mice.

C4A C4B

1.10e-052116212207352
Pubmed

Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.

C4A C4B

1.10e-052116227758680
Pubmed

Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.

C4A C4B

1.10e-052116222387014
Pubmed

The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts.

KALRN HPRT1

1.10e-052116224380811
Pubmed

Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.

C4A C4B

1.10e-052116223749435
Pubmed

Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality.

A1CF APOB

1.10e-052116216055734
Pubmed

Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.

C4A C4B

1.10e-052116223918728
Pubmed

Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.

C4A C4B

1.10e-05211623037333
Pubmed

Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.

C4A C4B

1.10e-052116211726230
Pubmed

Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.

C4A C4B

1.10e-05211624216347
Pubmed

Sequence determination of the thiolester site of the fourth component of human complement.

C4A C4B

1.10e-05211626950384
Pubmed

Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.

C4A C4B

1.10e-05211628660986
Pubmed

Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.

C4A C4B

1.10e-05211628428773
Pubmed

Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.

C4A C4B

1.10e-052116224638111
Pubmed

Transcriptional repression of C4 complement by hepatitis C virus proteins.

C4A C4B

1.10e-052116221345967
Pubmed

Murine bubblegum orthologue is a microsomal very long-chain acyl-CoA synthetase.

ACSBG1 ABCD1

1.10e-052116214516277
Pubmed

Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.

C4A C4B

1.10e-05211622572548
Pubmed

The complement component C4 of mammals.

C4A C4B

1.10e-05211622302180
Pubmed

Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.

C4A C4B

1.10e-052116222151770
Pubmed

C4d-positive chronic rejection: a frequent entity with a poor outcome.

C4A C4B

1.10e-052116218091514
Pubmed

Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.

C4A C4B

1.10e-052116229080553
Pubmed

Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.

C4A C4B

1.10e-05211626589636
Pubmed

C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.

C4A C4B

1.10e-052116225339671
Pubmed

A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.

C4A C4B

1.10e-052116217728371
Pubmed

Structure and organization of the C4 genes.

C4A C4B

1.10e-05211626149580
Pubmed

Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.

C4A C4B

1.10e-05211626149581
Pubmed

The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.

C4A C4B

1.10e-052116212115608
Pubmed

Biochemistry and biology of anaphylatoxins.

C4A C4B

1.10e-05211623542363
Pubmed

C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.

C4A C4B

1.10e-05211622387317
Pubmed

Platelet-activating factor production in the spinal cord of experimental allergic encephalomyelitis mice via the group IVA cytosolic phospholipase A2-lyso-PAFAT axis.

LPCAT1 PLA2G4A

1.10e-052116218802104
Pubmed

Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.

C4A C4B

1.10e-052116216908004
Pubmed

Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.

C4A C4B

1.10e-05211627365238
Pubmed

Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.

C4A C4B

1.10e-05211627391573
Pubmed

Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.

C4A C4B

1.10e-052116217971360
Pubmed

Clinical features of patients with homozygous complement C4A or C4B deficiency.

C4A C4B

1.10e-052116229928053
Pubmed

Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.

C4A C4B

1.10e-052116217971229
Pubmed

Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Genetic and immunologic studies.

C4A C4B

1.10e-05211626881182
Pubmed

Development and degeneration of cone bipolar cells are independent of cone photoreceptors in a mouse model of retinitis pigmentosa.

PDE6B GNAT3

1.10e-052116222952865
Pubmed

Partial C4 deficiency in juvenile idiopathic arthritis patients.

C4A C4B

1.10e-052116217921792
Pubmed

Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.

C4A C4B

1.10e-052116221880985
Pubmed

Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.

C4A C4B

1.10e-05211626978711
Pubmed

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.

C4A C4B

1.10e-052116235898513
Pubmed

Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.

C4A C4B

1.10e-052116228873507
Pubmed

Studies on the murine Ss protein: demonstration that the Ss protein is functionally the fourth component of complement.

C4A C4B

1.10e-0521162276882
Pubmed

Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4.

C4A C4B

1.10e-05211626832377
Pubmed

Recombination of two homologous MHC class III genes of the mouse (C4 and Slp) that accounts for the loss of testosterone dependence of sex-limited protein expression.

C4A C4B

1.10e-05211623794341
Pubmed

Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes.

C4A C4B

1.10e-052116222785613
Pubmed

Association between complement 4 copy number variation and systemic lupus erythematosus: a meta-analysis.

C4A C4B

1.10e-052116232691186
Pubmed

apoA-IV tagged with the ER retention signal KDEL perturbs the intracellular trafficking and secretion of apoB.

APOA4 APOB

1.10e-052116215258202
Pubmed

The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter.

C4A C4B

1.10e-05211628390682
Pubmed

Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp).

C4A C4B

1.10e-05211623902619
Pubmed

Structural polymorphism of murine C4 and its linkage to H-2.

C4A C4B

1.10e-05211627373044
Pubmed

The chemical structure of the C4d fragment of the human complement component C4.

C4A C4B

1.10e-05211623696167
Pubmed

Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups.

C4A C4B

1.10e-05211621357031
Pubmed

Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s.

C4A C4B

1.10e-052116216098595
Pubmed

Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura.

C4A C4B

1.10e-052116215787745
Pubmed

Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study.

C4A C4B

1.10e-052116230026462
Pubmed

A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B.

C4A C4B

1.10e-05211626559257
Pubmed

Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects.

C4A C4B

1.10e-052116234299197
Pubmed

Assessment of complement C4 gene copy number using the paralog ratio test.

C4A C4B

1.10e-052116220506482
Pubmed

Polymerase chain reaction based C4AQ0 and C4BQ0 genotyping: association with systemic lupus erythematosus in southwest Han Chinese.

C4A C4B

1.10e-052116212480675
Pubmed

Low C4, C4A and C4B gene copy numbers are stronger risk factors for juvenile-onset than for adult-onset systemic lupus erythematosus.

C4A C4B

1.10e-052116226800705
Pubmed

Murine complement C4 is not required for experimental autoimmune encephalomyelitis.

C4A C4B

1.10e-052116215390104
Pubmed

Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein.

C4A C4B

1.10e-05211621699796
Pubmed

Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp.

C4A C4B

1.10e-05211622997024
Pubmed

Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences.

C4A C4B

1.10e-05211623624865
Pubmed

Identification of the molecular basis of doxorubicin-induced cardiotoxicity.

A1CF TOP2B

1.10e-052116223104132
Pubmed

Determination of the loss of function complement C4 exon 29 CT insertion using a novel paralog-specific assay in healthy UK and Spanish populations.

C4A C4B

1.10e-052116221857912
Pubmed

Isolation of cDNA clones specifying the fourth component of mouse complement and its isotype, sex-limited protein.

C4A C4B

1.10e-05211626208559
Pubmed

The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement.

C4A C4B

1.10e-05211624514997
Pubmed

The inheritance of susceptibility to the Gross leukemia virus in mice.

C4A C4B

1.10e-05211625919331
Pubmed

An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene.

C4A C4B

1.10e-05211623167981
Pubmed

Role of RNA splicing in mediating lineage-specific expression of the von Willebrand factor gene in the endothelium.

VWF HPRT1

1.10e-052116223529929
Pubmed

The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates.

C4A C4B

1.10e-05211627545960
Pubmed

Insights on the relationship between complement component C4 serum concentrations and C4 gene copy numbers in a Western Australian systemic lupus erythematosus cohort.

C4A C4B

1.10e-052116230041577
Pubmed

Complete cDNA sequence of the fourth component of murine complement.

C4A C4B

1.10e-05211623862104
Pubmed

The BS variant of C4 protects against age-related loss of white matter microstructural integrity.

C4A C4B

1.10e-052116234358307
Pubmed

Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d.

C4A C4B

1.10e-052116218360261
Pubmed

Schizophrenia risk from complex variation of complement component 4.

C4A C4B

1.10e-052116226814963
Pubmed

Promoter elements of the mouse complement C4 gene critical for transcription activation and start site location.

C4A C4B

1.10e-05211628132550
Pubmed

Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A.

C4A C4B

1.10e-05211622395880
Pubmed

Effects of Complement C4 Gene Copy Number Variations, Size Dichotomy, and C4A Deficiency on Genetic Risk and Clinical Presentation of Systemic Lupus Erythematosus in East Asian Populations.

C4A C4B

1.10e-052116226814708
Pubmed

cDNA clone spanning the alpha-gamma subunit junction in the precursor of the murine fourth complement component (C4).

C4A C4B

1.10e-05211626192448
Pubmed

Complete primary structure of human C4a anaphylatoxin.

C4A C4B

1.10e-05211626167582
Pubmed

Slp is an essential component of an EDTA-resistant activation pathway of mouse complement.

C4A C4B

1.10e-05211621438267
Pubmed

Genetic deficiency of complement isoforms C4A or C4B predicts improved survival of metastatic renal cell carcinoma.

C4A C4B

1.10e-052116219150565
Pubmed

Elevated levels of endogenous apoptotic DNA and IFN-alpha in complement C4-deficient mice: implications for induction of systemic lupus erythematosus.

C4A C4B

1.10e-052116217506029
Pubmed

Low C4 gene copy numbers are associated with superior graft survival in patients transplanted with a deceased donor kidney.

C4A C4B

1.10e-052116223715124
Pubmed

Identification of the 5'-flanking regulatory region responsible for the difference in transcriptional control between mouse complement C4 and Slp genes.

C4A C4B

1.10e-05211623464002
Pubmed

Complete nucleotide and derived amino acid sequences of the fourth component of mouse complement (C4). Evolutionary aspects.

C4A C4B

1.10e-05211622993295
Pubmed

Identification of the site of sulfation of the fourth component of human complement.

C4A C4B

1.10e-05211623944109
InteractionFLT1 interactions

SRPRA APOB IPO4 PTK2B URB1 SVIL PLCG1 ARHGEF2

8.18e-061791148int:FLT1
InteractionCHN2 interactions

PDE6B GLI2 PRICKLE2 PLCL1 ARHGEF2 RAPGEF2

1.87e-05971146int:CHN2
InteractionPDLIM5 interactions

DCAF15 PDE6B CEP128 GLI2 PRICKLE2 NUCKS1 UBR3 ARHGEF2 RAPGEF2

2.53e-052731149int:PDLIM5
InteractionDAB2IP interactions

CUL4A KALRN CDKL5 PRICKLE2 ARHGEF2 RAPGEF2

2.63e-051031146int:DAB2IP
InteractionGRIN1 interactions

SPTA1 SHC3 BDKRB1 CDKL5 PTK2B PLA2G4A PLCG1

2.76e-051541147int:GRIN1
InteractionGRIN2B interactions

KALRN SPTA1 SHC3 CDKL5 PTK2B PLA2G4A PLCG1

5.18e-051701147int:GRIN2B
InteractionGIT1 interactions

KALRN PTK2B SRRT NUCKS1 PLCG1 CROCC PMF1

5.58e-051721147int:GIT1
InteractionCC2D1B interactions

FAT4 FAT3 SRRT NUCKS1

6.18e-05381144int:CC2D1B
InteractionSYNGAP1 interactions

KALRN PDE6B CDKL5 PTK2B PRICKLE2 PLCL1 ARHGEF2 RAPGEF2 AGAP1

6.29e-053071149int:SYNGAP1
InteractionSORBS1 interactions

DCAF15 KALRN CEP128 CDKL5 PRICKLE2 ARHGEF2

7.12e-051231146int:SORBS1
GeneFamilyPhospholipases|C2 domain containing phospholipases

PLA2G4A PLCL1 PLCG1

8.27e-0519823832
GeneFamilyAnkyrin repeat domain containing|NF-kappa B complex subunits

REL NFKB2

2.01e-0458221254
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

CNKSR1 FGD2 PHLDB1 PLCG1 ARHGEF2 AGAP1

3.47e-04206826682
GeneFamilyComplement system|Sushi domain containing

ITGAX C4A C4B

5.76e-0436823492
GeneFamilyC3 and PZP like, alpha-2-macroglobulin domain containing

C4A C4B

7.17e-0498221234
GeneFamilySH2 domain containing

SHC3 SHE PLCG1 SH2D7

1.15e-03101824741
GeneFamilyCadherin related

FAT4 FAT3

2.64e-031782224
GeneFamilyArmadillo repeat containing|Importins

KPNA6 IPO4

2.97e-0318822596
GeneFamilyEF-hand domain containing

LPCAT1 SPTA1 CAPN3 SLC25A25 PLCG1

3.19e-03219825863
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

FGD2 KALRN ARHGEF2

3.35e-0366823722
GeneFamilyApolipoproteins

APOA4 APOB

4.03e-0321822405
GeneFamilyG-patch domain containing|Minor histocompatibility antigens

CMTR1 GPATCH3

4.43e-0322822579
GeneFamilyETS transcription factor family

ETV4 SPDEF

7.12e-0328822534
GeneFamilyZinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors

ZFYVE27 FGD2

8.68e-033182281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIAA0408 FAT4 KALRN MYO7B FAT3 SPTA1 APOB

5.79e-0718411772cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIAA0408 FAT4 KALRN MYO7B FAT3 SPTA1 APOB

5.79e-071841177ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIAA0408 FAT4 KALRN MYO7B FAT3 SPTA1 APOB

5.79e-0718411772b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor

LPCAT1 ERBB4 SHC3 TOX3 PRICKLE2 PLCL1 AGAP1

6.01e-071851177673f0c688ae6984bc8027df2da335787924f4137
ToppCellLPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 VWF TBC1D20 TOX3 PRICKLE2 SHE RIPOR1

7.19e-071901177106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCellfacs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VWF APOA4 PLXND1 ATAD2 CEP128 ASPM

7.42e-071191176c3f1223356e7f245a460ea5568a223e34e458dc1
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FAT4 ABCC9 SHC3 GLI2 PRICKLE2 PLA2G4A PALLD

7.44e-071911177c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FAT4 ABCC9 SHC3 GLI2 PRICKLE2 PLA2G4A PALLD

7.44e-071911177cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

LPCAT1 ERBB4 SHC3 CDKL5 PLCL1 PRKG2 ARHGEF2

7.71e-07192117729f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCellfacs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC25A42 FAT3 SPTA1 GPATCH3 C4B SH2D7

5.89e-061701176b180ec9a1b79025a180c8559c27c31272410dea8
ToppCellfacs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC25A42 FAT3 SPTA1 GPATCH3 C4B SH2D7

5.89e-06170117637c647f67505aa1ff12a198df1eeddd9f406fe15
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ERBB4 SHC3 TOX3 PRICKLE2 PLCL1 AGAP1

7.66e-061781176f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor

ERBB4 SHC3 TOX3 PRICKLE2 PLCL1 AGAP1

9.55e-06185117698b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCellEpithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor

LPCAT1 ERBB4 SHC3 TOX3 PLCL1 AGAP1

1.01e-05187117681cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FAT4 ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.08e-051891176c734e5693808a0333139e87bd5be2597a9252afe
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FOXO3 FAT4 KALRN ABCC9 URB1 GLI2

1.11e-0519011761121eb607a984c59fbffe7220837fc178745aa55
ToppCell3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWF PLXND1 MYZAP GDPD5 UBR3 SHE

1.11e-05190117632400c62cb9de4c2b24af4206c21a0215ab12212
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FOXO3 FAT4 KALRN ABCC9 URB1 GLI2

1.11e-051901176048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FAT4 ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.11e-0519011762e592323085ba9c019d678ac2a784462ab470ed9
ToppCell3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWF PLXND1 MYZAP GDPD5 UBR3 SHE

1.11e-051901176b2bd2cb384bb8a5662064ed1aee68e905e1f780d
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FAT4 ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.11e-051901176445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC9 SHC3 GLI2 PRICKLE2 PLA2G4A PALLD

1.14e-051911176806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

ERBB4 SVIL PRICKLE2 PLCL1 RAPGEF2 AGAP1

1.18e-051921176e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellControl-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 VWF TBC1D20 TOX3 PRICKLE2 RIPOR1

1.21e-051931176aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCellControl-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 VWF TBC1D20 TOX3 PRICKLE2 RIPOR1

1.21e-051931176c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

FGD2 MYO7B REL PTK2B RIPOR1 SYVN1

1.25e-051941176ff661419b697aef51a53fdeac8d37d870d65f491
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

FAT4 VWF WNT2B PHLDB1 PRICKLE2 SHE

1.25e-05194117640842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

FAT4 KALRN FAT3 TBL1XR1 GLI2 PRICKLE2

1.29e-0519511760e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FAT4 ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.33e-051961176a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FAT4 ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.33e-0519611763e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

VWF KALRN ABCC9 PLXND1 MYZAP SHE

1.36e-0519711764e58bbf3ecb30b4c8199adcc04d2eb134d90de56
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_3|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

A1CF CCDC168 KCNH4 PARP6 GDPD5

3.93e-051441175ce5e219f2548b51440b8b3e1a9f011afd4510d19
ToppCellCOVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class

GDPD5 PPY PLCG1 SH2D7 AGAP1

4.34e-051471175baf15c773d7751bc6f64d4974a22738626f2b3ff
ToppCellfacs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ERBB4 IL22RA2 SVIL GNAT3 SH2D7

5.25e-0515311753b1b0cc8e9dd2b1484649789330713282ee44414
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

LPCAT1 ERBB4 PLCL1 PRKG2 AGAP1

6.30e-0515911758680b054622f573a82b1625fb93c2d5db81d1034
ToppCellTCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-7|TCGA-Stomach / Sample_Type by Project: Shred V9

KIAA0408 FAT3 ADHFE1 PLCL1 NMBR

6.89e-051621175b115b5799137122bd60696f8ae2aebadad6cd044
ToppCellPND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYZAP CLCA2 ASPM NUCKS1 SHE

7.09e-0516311757864e966c228282b4b63c43164dba3faba21026d
ToppCell3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYO7B FAT3 GNAT3 PLA2G4A SH2D7

7.51e-05165117534fd00be2b28716c871ad9fb356de84a299a0c01
ToppCelldroplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CNKSR1 ERBB4 ETV4 BDKRB1 TOX3

7.95e-051671175cf6206c506715cd846799c62cf7c06e3fa99f7af
ToppCelldroplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CNKSR1 ERBB4 ETV4 BDKRB1 TOX3

8.41e-05169117530141f76e9bfc2b4586429857c72dbc85ba65cc9
ToppCellE17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

VWF GCM2 PLXND1 UGDH PALLD

8.65e-0517011757fa022471e14ac8a3bc147c793368a4d56a8e591
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor

ERBB4 SHC3 TOX3 PLCL1 AGAP1

8.65e-051701175269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ERBB4 SHC3 PRICKLE2 PLCL1 AGAP1

8.65e-051701175a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FOXO3 FAT4 GLI2 MEIOSIN PALLD

8.89e-051711175972fab891135bd755d5526cbc5a963200067b0a6
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FOXO3 FAT4 GLI2 MEIOSIN PALLD

8.89e-0517111752a77ed79c6f2e700e789c80451a70ecb31639719
ToppCellfacs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WNT2B ABCC9 SHC3 PHC1 PLCL1

9.39e-051731175d78397e65e997ddb995111a810f0e2a4f67d0765
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

KALRN FAT3 SVIL PLCL1 PALLD

9.39e-051731175cb6389536195443633adb06e5f1b7483530773d1
ToppCellfacs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WNT2B ABCC9 SHC3 PHC1 PLCL1

9.39e-0517311753c852ffe22f4a5b632463086b08c669310684e80
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TBL1XR1 CLCA2 GLI2 TOX3 DDX25

9.64e-05174117542f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCellNS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FAT4 CAPN3 CCDC168 PMEL SHE

9.91e-051751175f6cd24d22f62469319f9d244e3e5de527d3d4d94
ToppCelldroplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZFYVE27 PLXND1 AXIN1 GDPD5 PLCL1

1.02e-04176117524b2e94ee5defcefb64a1f2447a2cc71b015b0fd
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor

LPCAT1 ERBB4 SHC3 TOX3 PLCL1

1.02e-0417611753fee8a367bb9755aca1b7fcc968b08e51b6e9436
ToppCelldroplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZFYVE27 PLXND1 AXIN1 GDPD5 PLCL1

1.05e-041771175f360f7099570d248531897b96e0de282e58f59e9
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.13e-041801175280ff5c8f292be1b88120db5ff1788b750644856
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.13e-041801175fdbd7c22044d9328a1e06e2f9a4451529d1df767
ToppCellMS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster

MORC4 CEP128 PHC1 URB1 RAPGEF2

1.13e-0418011757ca083616926d98420fa11a6e5ebc981623f79ac
ToppCellcellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SLC25A42 PDE6B CEP128 ITGAX PTK2B

1.19e-0418211758ccffcbae28c374fd4161fb0d4cf2c49fae557f6
ToppCell3'_v3-GI_small-bowel-Myeloid_Dendritic|GI_small-bowel / Manually curated celltypes from each tissue

FGD2 MYZAP ITGAX IL22RA2 PPY

1.22e-0418311756109199cf25b28831193a5ed7925b5bf38c6eb43
ToppCell3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWF PLXND1 MYZAP GDPD5 SHE

1.29e-041851175fb84fcf7f51f53489bcb3962fa9cb483e48257ed
ToppCell3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWF PLXND1 MYZAP GDPD5 SHE

1.32e-0418611759d250d5ae7cf9129be05b41d70cb6c3a046c5f1e
ToppCell10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

VWF KALRN PLXND1 SHE PLCG1

1.32e-041861175a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCellwk_08-11-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

VWF PLXND1 GDPD5 SHE UPP2

1.35e-041871175a27aa97aa6508a3ffe92c2b6bb0511a95650a390
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LPCAT1 ETV4 TOX3 UGDH PRKG2

1.39e-0418811757471c194276161422326647f09022e94f3d1640c
ToppCell343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells)

KALRN WNT2B MYZAP PHLDB1 PRICKLE2

1.39e-041881175fe7143c36e4a883745862d3c3147cf751b440e46
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LPCAT1 ETV4 TOX3 UGDH PRKG2

1.39e-041881175053c251d3ddbeb866f34565aefca4535517b4387
ToppCell343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|343B / Donor, Lineage, Cell class and subclass (all cells)

KALRN WNT2B MYZAP PHLDB1 PRICKLE2

1.39e-041881175cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437
ToppCellE17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ETV4 ABCC9 PLCL1 RAPGEF2 SEPTIN7

1.42e-04189117526cfe5b7e7f477f225f4e9f25f983f432f01e183
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KIAA0408 FAT3 GLI2 PLCL1 PALLD

1.42e-04189117545e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.46e-0419011752306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KALRN FAT3 ABCC9 GLI2 PALLD

1.46e-04190117570c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.46e-0419011751f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.49e-041911175a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KALRN ABCC9 GLI2 PLA2G4A PALLD

1.49e-041911175a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCellhuman_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells)

FGD2 REL ITGAX PTK2B PLCL1

1.49e-0419111753b59bfc6c106ae8a3fbcd4a74bd128c485724921
ToppCellControl-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KIAA0408 FAT3 GLI2 PLCL1 PALLD

1.49e-04191117514057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCellChildren_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

ERBB4 TOX3 PRICKLE2 PLCL1 AGAP1

1.49e-04191117523776c7302cead3881b39127398f3b3e0d27885e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KALRN FAT3 ABCC9 GLI2 PALLD

1.49e-041911175107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

LPCAT1 ERBB4 SHC3 PRKG2 ARHGEF2

1.49e-041911175ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCellEpithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor

LPCAT1 ERBB4 SHC3 PRKG2 ARHGEF2

1.49e-041911175d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

FAT4 VWF MYZAP PRICKLE2 SHE

1.49e-041911175dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KALRN FAT3 ABCC9 GLI2 PALLD

1.49e-041911175bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KALRN ABCC9 GLI2 PLA2G4A PALLD

1.49e-0419111758f6d592edc32fdb901af30501d4360512334e8c2
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.53e-0419211754022f208eb5db760abd0aac782a25e8ab63efc64
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.53e-0419211759093a9e94a25682d109a7f6edc256a25a61103a0
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KALRN ABCC9 GLI2 PLA2G4A PALLD

1.53e-041921175bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWF PLXND1 MYZAP GDPD5 SHE

1.53e-041921175fa0ef05a32c661bdd59b5a9b6f75fd647ee937f3
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC9 SHC3 GLI2 PLA2G4A PALLD

1.53e-0419211759ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWF PLXND1 MYZAP GDPD5 SHE

1.53e-0419211754e63d95f75fe6eb3f817e84528883e95093c5bbd
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KALRN ABCC9 GLI2 PLA2G4A PALLD

1.53e-0419211750ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

GCM2 SPTA1 KCNH4 SPDEF SH2D7

1.57e-041931175315840bc48899f3a36d57b19197509de19716e3d
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CNKSR1 SRPRA CEP128 ASPM SYVN1

1.57e-041931175227d82059a9f99937e0188ff57f2d0e485ebfe69
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CNKSR1 SRPRA CEP128 ASPM SYVN1

1.57e-04193117538bb14df7f05c29565a1c7f175fafe636e543bf8
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KALRN ABCC9 GLI2 PLA2G4A PALLD

1.57e-041931175c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCelldroplet-Bladder-nan-3m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VWF ABCC9 PLXND1 PPY SHE

1.57e-0419311758be24713f8ba2545b7647d1994e9e993623ddaa3
ToppCelldroplet-Bladder-nan-3m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VWF ABCC9 PLXND1 PPY SHE

1.57e-04193117519dfc4a2c91fcea4f5991e7c44df46faeecb06b8
ToppCelldroplet-Bladder-nan-3m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VWF ABCC9 PLXND1 PPY SHE

1.57e-041931175351e0acd411a9eb0dbc0e358d0d1e3759753fa40
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CNKSR1 SRPRA CEP128 ASPM SYVN1

1.57e-0419311753ba6d44248690b80f4caf791d463e60f1ab816c4
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KALRN ABCC9 GLI2 PLA2G4A PALLD

1.57e-0419311755b602b1702283184bd3943c2a6f2290b7c37e407
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CNKSR1 SRPRA CEP128 ASPM SYVN1

1.57e-041931175ce3873ece35fd2155ea235cb3c8bcd235cc0ebde
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CNKSR1 SRPRA CEP128 ASPM SYVN1

1.57e-0419311758f57b0473a2c2c07f83e5fe70f16862b1bb3b514
DrugLactobionic acid [96-82-2]; Up 200; 11.2uM; PC3; HT_HG-U133A

A1CF CAPN3 REL NCAPH2 PHLDB1 CLCA2 PRKG2 ARHGEF2 SEPTIN7

7.77e-0719711696605_UP
DrugAG213

ERBB4 PTK2B ADHFE1 C4A PLCG1 TOP2B

6.32e-06891166CID005328803
DrugEtofenamate [30544-47-9]; Down 200; 10.8uM; HL60; HT_HG-U133A

CYP1A2 DCAF15 MRM1 CAPN3 SRRT SETDB1 GPATCH3 PALLD

7.51e-0619611682907_DN
Drugsodium linoleate

CYP1A2 FAT4 LPCAT1 ERBB4 APOA4 APOB ITGAX ACSBG1 NFKB2 PLA2G4A

1.02e-0534211610CID000003931
DiseaseMalignant neoplasm of skin

ERBB4 XPA PTK2B GLI2

8.45e-05591154C0007114
DiseaseSkin Neoplasms

ERBB4 XPA PTK2B GLI2

8.45e-05591154C0037286
Diseasediabetic angiopathy (implicated_via_orthology)

BDKRB1 PTK2B

2.24e-0461152DOID:11713 (implicated_via_orthology)
Diseasefamilial combined hyperlipidemia (is_marker_for)

VWF APOB

2.24e-0461152DOID:13809 (is_marker_for)
Diseaseadrenoleukodystrophy (implicated_via_orthology)

ACSBG1 ABCD1

3.12e-0471152DOID:10588 (implicated_via_orthology)
Diseasethalamus volume

FOXO3 FAT3 NUCKS1 AGAP1

3.48e-04851154EFO_0006935
DiseaseAtrial Fibrillation

CUL4A ERBB4 VWF ABCC9 NUCKS1

4.18e-041601155C0004238
Diseasemelanoma

FAT4 ERBB4 XPA PMEL PTK2B SETDB1

4.35e-042481156C0025202
Diseaseciliopathy (implicated_via_orthology)

RPGRIP1L KIAA0753 SCLT1

5.13e-04401153DOID:0060340 (implicated_via_orthology)
DiseaseAdenocarcinoma of large intestine

ERBB4 TBL1XR1 AXIN1 PRKG2

5.52e-04961154C1319315
Diseaseoccupational attainment

ERBB4 PLCL1 AGAP1

5.93e-04421153EFO_0020977
Diseasecardiovascular system disease (is_marker_for)

APOA4 APOB

6.64e-04101152DOID:1287 (is_marker_for)
Diseaseschizophrenia (is_marker_for)

VWF APOA4 SETDB1

6.80e-04441153DOID:5419 (is_marker_for)
Diseasecoffee consumption measurement

FOXO3 EHBP1 CYP1A2 APOA4 SETDB1

7.50e-041821155EFO_0006781
DiseaseAcute Promyelocytic Leukemia

TBL1XR1 ITGAX GLI2

7.75e-04461153C0023487
Diseasevisual epilepsy (is_implicated_in)

CDKL5 ASPM

8.09e-04111152DOID:11832 (is_implicated_in)
DiseaseHerpes Zoster, response to tofacitinib

VWF TOX3

9.69e-04121152EFO_0006510, EFO_0600024
DiseaseHyperlipoproteinemia Type IIb

APOA4 APOB

1.14e-03131152C1704417
Diseasesexual dimorphism measurement

FOXO3 APOA4 APOB FAM133B SETDB1 GPATCH3 GLI2 NUCKS1 SPDEF PRKG2 NMBR CROCC

1.29e-03110611512EFO_0021796
DiseaseAutosomal recessive primary microcephaly

PHC1 ASPM

1.53e-03151152cv:C3711387
Diseasevery low density lipoprotein cholesterol measurement, lipid measurement

A1CF CAPN3 APOA4 APOB PLCG1

1.74e-032201155EFO_0004529, EFO_0008317
DiseaseHyperlipoproteinemia Type IIa

APOA4 APOB

1.74e-03161152C0745103
Diseaseoral squamous cell carcinoma (is_marker_for)

ERBB4 AXIN1 PLCG1

1.93e-03631153DOID:0050866 (is_marker_for)
DiseaseHypercholesterolemia, Familial

APOA4 APOB

2.21e-03181152C0020445
DiseaseMalignant neoplasm of liver

XPA TOX3 UGDH PRICKLE2

2.35e-031421154C0345904
DiseaseLiver neoplasms

XPA TOX3 UGDH PRICKLE2

2.35e-031421154C0023903
Diseasecoronary artery disease

EHBP1 CYP1A2 FAT4 ERBB4 APOA4 APOB RSBN1 GDPD5 PLCL1 PLCG1 RAPGEF2 PALLD

2.44e-03119411512EFO_0001645
Diseaselaryngeal squamous cell carcinoma (is_marker_for)

ERBB4 PLCG1

2.47e-03191152DOID:2876 (is_marker_for)
Diseaseglomerulonephritis (is_marker_for)

BDKRB1 PTK2B

2.47e-03191152DOID:2921 (is_marker_for)
Diseasefactor VIII measurement, Ischemic stroke

VWF PMF1

2.47e-03191152EFO_0004630, HP_0002140
Diseasecoagulation factor measurement

VWF ASPM

2.73e-03201152EFO_0004634
DiseaseRetinal Degeneration

RPGRIP1L PDE6B

3.01e-03211152C0035304
Diseaselung cancer (is_implicated_in)

XRN2 AXIN1 SETDB1

3.06e-03741153DOID:1324 (is_implicated_in)
DiseaseParoxysmal atrial fibrillation

CUL4A ERBB4 VWF NUCKS1

3.30e-031561154C0235480
Diseaseprostate cancer (is_marker_for)

FOXO3 ERBB4 PTK2B SETDB1

3.30e-031561154DOID:10283 (is_marker_for)
Diseasefamilial atrial fibrillation

CUL4A ERBB4 VWF NUCKS1

3.30e-031561154C3468561
DiseasePersistent atrial fibrillation

CUL4A ERBB4 VWF NUCKS1

3.30e-031561154C2585653
DiseaseSplenomegaly

CYP1A2 BDKRB1

3.31e-03221152C0038002
DiseaseAutosomal Recessive Primary Microcephaly

PHC1 ASPM

3.31e-03221152C3711387
DiseasePrimary microcephaly

PHC1 ASPM

3.31e-03221152C0431350
DiseaseGranulomatous Slack Skin

NFKB2 PLCG1

3.31e-03221152C0376407
Diseasevery low density lipoprotein cholesterol measurement

EHBP1 A1CF CAPN3 APOA4 APOB

3.57e-032601155EFO_0008317
Diseaseobsolete Mendelian syndromes with cleft lip/palate

MRM1 SVIL

3.61e-03231152MONDO_0015335
DiseaseLymphoma, T-Cell, Cutaneous

NFKB2 PLCG1

3.61e-03231152C0079773
Diseasehippocampal sclerosis of aging

MRM1 ABCC9

3.61e-03231152EFO_0005678
Diseaseepilepsy (implicated_via_orthology)

KALRN BDKRB1 KCNU1 PRICKLE2

3.86e-031631154DOID:1826 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
RMARDPQRYLVIQGD

ERBB4

976

Q15303
YRVLVHPMASRRQQR

BDKRB1

136

P46663
TSRNLRQVDQMLGRY

CEP128

51

Q6ZU80
RMANYRNTSEIPLVL

AGAP1

161

Q9UPQ3
VRYRVFALDQKMRPS

C4B

156

P0C0L5
RAIIRAPSVREIYMN

A1CF

371

Q9NQ94
RLQEIYNRMDPRAQT

ARHGEF2

441

Q92974
SNRETIYPNASLLMR

CEACAM8

96

P31997
IYPNASLLMRNVTRN

CEACAM8

101

P31997
RRQYSLTVQAMDRGV

FAT4

316

Q6V0I7
EPNAQAQMYRLTLRT

AP2A1

946

O95782
NVIRVRRYVFFMNPQ

ABCC9

186

O60706
RQLRLLFDQAYQMRP

ATAD2

511

Q6PL18
DVQVMYAIRGNRIPR

DDX25

196

Q9UHL0
QRAAVLIQATFRMYR

ASPM

2481

Q8IZT6
YYSPRRVRDMQVAIA

C17orf113

171

A0A1B0GUU1
NRPAMNYDKLSRSLR

ETV4

386

P43268
SRMSQRYGDVLQIRI

CYP1A2

66

P05177
FRNLRPMLAADAQRY

ITGAX

746

P20702
RVPHFMQDLARYRQQ

KIAA0895L

436

Q68EN5
PRLRRDTQQGMYDAV

ACP7

151

Q6ZNF0
YRVSNMDGRLRNPDQ

ABCD1

181

P33897
EQLRRQLTPYAQRME

APOA4

151

P06727
MSRPVRNRKVVDYSQ

NUCKS1

1

Q9H1E3
SYKNNALNPEEMRRR

KPNA6

16

O60684
IYTLRNQDMQAAVRR

OR4D2

286

P58180
NPALYASNVRRVMAE

LPCAT1

286

Q8NF37
ALSADRYRAIVNPMD

NMBR

136

P28336
VNPRSAEDQRQLYAM

GNAT3

96

A8MTJ3
RVPMDQAIRLYRERA

RPGRIP1L

736

Q68CZ1
MARATLAQRSYLPQI

MYG1

361

Q9HB07
LAQAQRLIRMYSGRR

GPATCH3

111

Q96I76
AKRYRPQIMAALEAN

PLXND1

1881

Q9Y4D7
MYRQRNGVAELATRL

PDE6B

96

P35913
YQRKERSTAVMRSQP

KALRN

2241

O60229
VMAPYFLQQRDTLRR

PMF1

136

Q6P1K2
FGNVTAIIQRMYSRR

KCNH4

471

Q9UQ05
VRQMQGHLSPRSYRN

KIAA0408

521

Q6ZU52
QRMIRTSPNSLVAYI

GLI2

246

P10070
RSYNPEQIMLSAAVR

GDPD5

526

Q8WTR4
AEIYQPMLDRRSQRS

IL22RA2

241

Q969J5
LRNFVMPLRASNYTR

KCNU1

731

A8MYU2
MTQQERRPYCTKARR

MEIOSIN

581

C9JSJ3
MRRTAQARDEQYRNF

PRKG2

266

Q13237
ATPEQMAQYAADLRR

PPY

41

P01298
YIKALNRNSDRSIPM

HPRT1

81

P00492
NGQPRLTYEERMARR

PALLD

921

Q8WX93
PLRAREDYDQFMRQR

PRICKLE2

716

Q7Z3G6
NMARDQRSRATLYAL

APOB

431

P04114
RQLQVQDMRGRYEAS

CROCC

531

Q5TZA2
NRVAYMNPIAMARSR

FAM133B

6

Q5BKY9
ANYERPRMNANSLLA

CRY2

251

Q49AN0
ASRAPSKQRYVQEVM

AXIN1

721

O15169
SKQRYVQEVMRRGRA

AXIN1

726

O15169
VPDLAQMYQLFSRVR

CUL4A

316

Q13619
IMVRDQEFPYRRNLA

FAT3

1536

Q8TDW7
RRVNMNAAARPYHIQ

ACSBG1

666

Q96GR2
SQYIENRPEMKRQRS

EHBP1

1021

Q8NDI1
VLKISFRRNDPMERY

FGD2

326

Q7Z6J4
SILPNTRMYSRLNAE

CCDC168

1146

Q8NDH2
QMALGQRRNPYATLR

CFAP141

36

Q5VU69
QRRNPYATLRMQDTM

CFAP141

41

Q5VU69
MEQERNARYRTPKIL

PTK2B

691

Q14289
TYINMREVSQRFRLP

CAPN3

536

P20807
YNRTNRSRMPNLNDL

CDKL5

941

O76039
VVPSYMQAVNRERER

IPO4

751

Q8TEX9
NLRPMRERTAVQGQY

DCAF15

426

Q66K64
RARTRANPYEMIRGV

CMTR1

216

Q8N1G2
VRYRVFALDQKMRPS

C4A

156

P0C0L4
VQRYNRMNTIPQTRS

PARP6

536

Q2NL67
AMVESIEYRRQNPSR

PLA2G4A

711

P47712
MAAAARARVAYLLRQ

ADHFE1

1

Q8IWW8
APRRRAVSMDNSNKY

FOXO3

246

O43524
NQMRREGIRYARIQL

RSBN1

656

Q5VWQ0
RRAIRNMNTLYPDAT

SYVN1

266

Q86TM6
MPALVQRRIADYEAA

TIMM10B

71

Q9Y5J6
PASNRSMRSDRNTYV

UPP2

6

O95045
PNYDAREIVNNVRRM

TOP2B

886

Q02880
TRQRRMNARYQTQPV

SVIL

841

O95425
RPRRQKLDTMCRYQV

MRM1

101

Q6IN84
RRSAIKRQMASFYQP

GCM2

171

O75603
RRRLQNEMTTPSLDY

MORC4

576

Q8TE76
MLPRTKYNRFRNDSV

SHC3

1

Q92529
QSASYPLDVVRRRMQ

SLC25A42

241

Q86VD7
IRRQEQAARSARMLY

KIAA0753

256

Q2KHM9
YRRRLMKQDFSVPQL

PMEL

616

P40967
AVRNRRAGYEVRQMA

RANBP6

56

O60518
RAGYEVRQMAAALLR

RANBP6

61

O60518
RYRATVIQAFRDMNR

URB1

1951

O60287
AVMPDVVQTRQQAYR

TBL1XR1

86

Q9BZK7
TCLSRVRPMRNEQYR

SETDB1

581

Q15047
NRMVRGDPRAIVEYR

SRRT

851

Q9BXP5
RIYVAIRAMDRNSLQ

CLCA2

861

Q9UQC9
QQSAALPRRYMLRER

NCAPH2

286

Q6IBW4
SFMRRNRDPQLNERV

CNKSR1

606

Q969H4
YPLALVRTRMQAQAS

SLC25A25

396

Q6KCM7
PDYNVALQRSRMVAR

RAPGEF2

1426

Q9Y4G8
MNDYQRRRFASRIID

UGDH

306

O60701
RIYPSAMRIDSSNLN

PLCL1

641

Q15111
ASQEPQRMSRNFVRY

VWF

1386

P04275
YLNAESRVNRRQMPD

SEPTIN7

141

Q16181
NRPAMNYDKLSRSIR

SPDEF

296

O95238
SQVASNPRQAAYEMR

XRN2

451

Q9H0D6
LSQVNYRVPNMRFLR

PLCG1

181

P19174
IIYADLRRMNQARLG

SH2D7

241

A6NKC9
LRDIMDAQRRQRPYV

SRPRA

406

P08240
SSRPQIAQMSLYERQ

PHC1

21

P78364
EIIEQPRQRGMRFRY

REL

11

Q04864
RYEAIVRARNSMQLL

SCLT1

326

Q96NL6
RVMALYDFQARSPRE

SPTA1

981

P02549
TQVSQYRQDPSLIMR

TOX3

141

O15405
MREKQFSQARPLTRY

PHLDB1

1211

Q86UU1
LMLRQARLAARPYSA

XPA

36

P23025
RVVSEYRASLQQRMN

ZFYVE27

221

Q5T4F4
SNMRHFINYVRVRVP

UBR3

991

Q6ZT12
ASAQQRPDMVLRQRF

TBC1D20

331

Q96BZ9
PYDAQQMITEIRRRG

SHE

231

Q5VZ18
PSLREQAFYNMLRRQ

RIPOR1

356

Q6ZS17
RQRQLCQRYPDIMRS

WNT2B

81

Q93097
RSQPLARQYQAMRQR

MYO7B

821

Q6PIF6
QTGRTREIVMPSRNY

MYZAP

436

P0CAP1
APEMLQRAREYNARL

NFKB2

436

Q00653